Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma
Multiple myeloma (MM), a plasma cell neoplasm, is an incurable hematological malignancy characterized by complex genetic and prognostic heterogeneity. Gain or amplification of chromosome arm 1q21 (1q21+) is the most frequent adverse chromosomal aberration in MM, occurring in 40% of patients at diagn...
Main Author: | Ichiro Hanamura |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/2/256 |
Similar Items
-
The amplification of 1q21 is an adverse prognostic factor in patients with multiple myeloma in a Chinese population
by: Yu W, et al.
Published: (2016-01-01) -
Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets
by: Jessica Burroughs Garcìa, et al.
Published: (2021-06-01) -
Prognostic value of 1q21 amplification in multiple myeloma
by: T V Abramova, et al.
Published: (2017-07-01) -
Duplicación 2 q 2.1- q 3.1: reporte de un caso Duplication 2 q 2.1- q 3.1: a case report
by: Marta M. Acosta Sabatés, et al.
Published: (2008-03-01) -
Chiari I malformation in a Waardenburg phenotype with multiple malformations and 1q21.1 microdeletion
by: Agostino Berio, et al.
Published: (2021-01-01)